Cancer genomic medicine in Japan and the roles of pharmacists

被引：1

作者：

Aomori, Tohru ^{[1
,2
]}

Sakurai, Hiroomi ^{[2
]}

Nishihara, Hiroshi ^{[3
]}

机构：

[1] Keio Univ, Div Hosp Pharm Sci, Fac Pharm, Tokyo, Japan

[2] Keio Univ Hosp, Dept Pharm, Tokyo, Japan

[3] Keio Univ, Keio Canc Ctr, Genom Unit, Sch Med, Tokyo, Japan

来源：

PHARMACOGENETICS AND GENOMICS | 2022年 / 32卷 / 06期

关键词：

cancer genomic medicine; precision medicine;

D O I：

10.1097/FPC.0000000000000476

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Cancer genomic medicine (CGM) is a medical service that provides optimized treatment for each patient based on genes, biomarkers, environment, and lifestyle. In Japan, the approval of designed core hospitals for CGM started in 2017. In June 2019, two types of cancer gene panel tests became available in the national health insurance system, and CGM was socially implemented. While CGM is still in its infancy and there are some issues that need to be resolved, there are cases where the treatment has shown dramatic results. The present review highlights the CGM system in Japan, the issues it faces, and the role of pharmacists in this system.

引用

页码：242 / 245

页数：4

共 50 条

[21] Cancer pain management and the roles of pharmacists in China
Chengliang Zhang
Jian Xiao
Zaoqin Yu
Shusen Sun
Dong Liu
International Journal of Clinical Pharmacy, 2021, 43 : 383 - 385
[22] Roles of Dental Care in Disaster Medicine in Japan
Yamazoe J.
Naito H.
Current Oral Health Reports, 2022, 9 (3) : 111 - 118
[23] The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan
Sunami, Kuniko
Naito, Yoichi
Aimono, Eriko
Amano, Toraji
Ennishi, Daisuke
Kage, Hidenori
Kanai, Masashi
Komine, Keigo
Koyama, Takafumi
Maeda, Takahiro
Morita, Sachi
Sakai, Daisuke
Kohsaka, Shinji
Tsuchihara, Katsuya
Yoshino, Takayuki
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (03) : 443 - 449
[24] "PleSSision": A Pathologist Edited Multigene Genomic Test Promotes Cancer Precision Medicine in Japan
Aimono, E.
Yanagita, E.
Matsuoka, R.
Kato, Y.
Hayashi, H.
Imai, M.
Tanishima, S.
Nishihara, H.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 1011 - 1011
[25] The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan
Kuniko Sunami
Yoichi Naito
Eriko Aimono
Toraji Amano
Daisuke Ennishi
Hidenori Kage
Masashi Kanai
Keigo Komine
Takafumi Koyama
Takahiro Maeda
Sachi Morita
Daisuke Sakai
Shinji Kohsaka
Katsuya Tsuchihara
Takayuki Yoshino
International Journal of Clinical Oncology, 2021, 26 : 443 - 449
[26] Patient survey on cancer genomic medicine in Japan under the national health insurance system
Kage, Hidenori
Akiyama, Nana
Chang, Hyangri
Shinozaki-Ushiku, Aya
Ka, Mirei
Kawata, Junichi
Muto, Manabu
Okuma, Yusuke
Okita, Natsuko
Tsuchihara, Katsuya
Kikuchi, Junko
Shirota, Hidekazu
Hayashi, Hideyuki
Kokuryo, Toshio
Yachida, Shinichi
Hirasawa, Akira
Kubo, Makoto
Kenmotsu, Hirotsugu
Tanabe, Masahiko
Ushiku, Tetsuo
Muto, Kaori
Seto, Yasuyuki
Oda, Katsutoshi
CANCER SCIENCE, 2024, 115 (03) : 954 - 962
[27] Precision medicine in oncology: New practice models and roles for oncology pharmacists
Walko, Christine
Kiel, Patrick J.
Kolesar, Jill
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (23) : 1935 - 1942
[28] Genomic Medicine for Cancer Prognosis
Mathur, Aarti
Zeiger, Martha A.
JOURNAL OF SURGICAL ONCOLOGY, 2015, 111 (01) : 31 - 37
[29] Genomic Medicine for Cancer Diagnosis
Gordon, Benjamin L.
Finnerty, Brendan M.
Aronova, Anna
Fahey, Thomas J., III
JOURNAL OF SURGICAL ONCOLOGY, 2015, 111 (01) : 24 - 30
[30] Genomic medicine and hereditary cancer
Sugano, Kokichi
ANNALS OF ONCOLOGY, 2018, 29 : 40 - 40

← 1 2 3 4 5 →